Coya Therapeutics, Inc.COYANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+33.2%
5Y CAGR+76.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+33.2%/yr
Annual compound
5Y CAGR
+76.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
17.1x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$11.45M+28.9%
2024$8.89M+13.4%
2023$7.83M+61.6%
2022$4.85M+109.6%
2021$2.31M+245.8%
2020$668700.00-